NCT04662723View on ClinicalTrials.gov

Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

PHASE4RecruitingINTERVENTIONAL
Enrollment

878

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

June 1, 2026

Study Completion Date

December 31, 2028

Conditions
GlomerulonephritisImmunoglobulin A Nephropathy
Interventions
DRUG

Corticosteroid

To reduce the progression of renal damage in IgAN Patients

DRUG

Renin-angiotensin sytem blockers

To reduce the progression of renal damage in IgAN Patients

DRUG

Sodium-glucose cotransporter 2 inhibitor

To reduce the progression of renal damage in IgAN Patients

Trial Locations (2)

70124

RECRUITING

francesco paolo Schena, Bari

RECRUITING

francesco paolo Schena, Bari

All Listed Sponsors
collaborator

University of Bari

OTHER

lead

Fondazione Schena

OTHER